Quest Diagnostics - 28 Year Stock Split History | DGX

Stock split history for Quest Diagnostics since 1996. Prices shown are actual historical values and are not adjusted for either splits or dividends. Please see the "Historical Prices" tab for adjusted price values.
Quest Diagnostics Annual Stock Splits
Quest Diagnostics Quarterly Stock Splits
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $15.213B $9.252B
Quest Diagnostics, Inc. is the provider of commercial laboratory services. Quest provides lab testing services to physicians, hospitals, managed care organizations, employers, government institutions and other clinical laboratories. The company consists of 2 business groups - Diagnostic Information Services and Diagnostic Solutions. The company's focus is on two elements - to accelerate growth and to drive operational excellence. Restore Growth: The company has adopted seven tactical approaches to accelerate growth such as sales and marketing; development of esoteric testing through a disease focus; partnerships with hospitals and successful testing of international IDNs; creation of value from information assets; leadership in companion diagnostics; extension into adjacent markets. Drive Operational excellence: The company plans to focus on four strategic requirements - to enhance end-to-end customer value chain, enterprise information technology architecture, business performance tools and cost excellence.
Stock Name Country Market Cap PE Ratio
Fresenius SE (FSNUY) Germany $17.425B 10.54
DaVita (DVA) United States $12.075B 15.00
Chemed (CHE) United States $8.786B 27.23
Encompass Health (EHC) United States $8.647B 22.13
Elanco Animal Health (ELAN) United States $6.680B 15.19
Option Care Health (OPCH) United States $5.270B 19.95
RadNet (RDNT) United States $3.877B 104.94
Amedisys (AMED) United States $3.018B 21.38
LifeStance Health (LFST) United States $2.668B 0.00
Astrana Health (ASTH) United States $2.125B 28.74
Addus HomeCare (ADUS) United States $1.712B 24.49
U.S Physical Therapy (USPH) United States $1.591B 42.58
Pennant (PNTG) United States $0.628B 33.19
Aveanna Healthcare Holdings (AVAH) United States $0.454B 0.00
Atai Life Sciences (ATAI) Germany $0.343B 0.00
Daxor (DXR) United States $0.046B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.025B 0.00
ATI Physical Therapy (ATIP) United States $0.020B 0.00
Psychemedics (PMD) United States $0.015B 0.00
Ontrak (OTRK) United States $0.013B 0.00
Novo Integrated Sciences (NVOS) United States $0.010B 0.00
IMAC Holdings (BACK) United States $0.005B 0.00